Kaposi's sarcoma in renal-transplant recipients: experience at the Catholic University in Rome, 1988-1996

Dermatology : International Journal for Clinical and Investigative Dermatology
I Lesnoni La ParolaD Cerimele

Abstract

The incidence of Kaposi's sarcoma (KS) in patients transplanted at the Organ Transplant Center of Catholic University in Rome appears to have increased in recent years. To describe the clinical characteristics of KS in a group of transplant recipients. Over 8 years, a total of 302 renal-transplant recipients were followed. When KS was suspected, histology and staging procedures were performed. Ten cases of KS have been diagnosed (8 males, 2 females; age 46.4 +/- 9.4 years); 4 of them were on triple therapy. All the patients were HIV-1 seronegative. The onset of KS occurred 3 months to 4 years after transplantation (21.1 +/- 17.6 months). The disease was limited to the skin in 6 cases and involved internal organs in the remaining 4. Four patients experienced complete remission of the disease following reduction of the immunosuppressive therapy. The high incidence of KS in this population (2.98%), as compared to that reported in other transplant patient groups, suggests that, besides viral infection, genetic predisposition may play a pathogenetic role. However, immunosuppression is the leading factor in transplant patients.

Citations

Oct 9, 2007·Journal of Cancer Research and Clinical Oncology·Fabrizio Di BenedettoGiorgio E Gerunda
Mar 12, 2004·Transplantation Proceedings·A A Al-Khader, F A M Shaheen
Jan 5, 2000·Transplantation Proceedings·H KarakayaliM Haberal
Mar 30, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·K StrandM L Bosch
Feb 13, 2003·International Journal of Dermatology·Josune MitxelenaJosé Luis Díaz-Pérez
Apr 6, 2000·The New England Journal of Medicine·K Antman, Y Chang
Oct 24, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Nilesh PatelAlbert S Braverman
Jun 9, 2005·Critical Reviews in Clinical Laboratory Sciences·Adina CohenRonit Sarid
Oct 2, 2012·Dermatologic Clinics·Joshua W HagenA Neil Crowson
May 4, 2010·International Immunopharmacology·Francesco UrsiniRosa Daniela Grembiale
Jul 21, 2009·Journal of the American Academy of Dermatology·Meghan Dubina, Gary Goldenberg
Jul 22, 2008·Journal of the American Academy of Dermatology·Robert A SchwartzLaura Scuderi
Aug 31, 2004·Journal of Surgical Oncology·Robert A Schwartz
Jun 15, 2005·Clinical and Experimental Dermatology·M T FierroM G Bernengo
May 22, 2004·Artificial Organs·George ZavosAlkiviadis Kostakis
Nov 25, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Amgad E El-AgroudyMohamed A Ghoneim
Dec 13, 2006·BJU International·Wen-Wei FengYing-Chin Ko
May 24, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·Giovanni StalloneLoreto Gesualdo
Mar 11, 2010·Pediatric Transplantation·Coşkun CeltikOzlem Durmaz
Feb 20, 1999·Journal of the American Academy of Dermatology·P JensenS Simonsen
Jul 18, 2002·Dermatologic Clinics·Paul T Martinelli, Stephen K Tyring
Aug 12, 2015·World Journal of Gastrointestinal Pharmacology and Therapeutics·Ann Joo LeeJuan Carlos Munoz
Jul 22, 1999·European Journal of Haematology·A ZeidmanM Mittelman
Mar 19, 1999·Journal of Cutaneous Medicine and Surgery·K J SmithH G Skelton
Nov 18, 2000·Pediatric Transplantation·M HaberalN Bilgin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.